XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.200
0.00 (0.00%)
Sep 8, 2026, 11:33 AM EDT - Market open
XBiotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 109.53 | 125.55 | 172.68 | 200.02 | 157.31 | 236.98 |
Short-Term Investments | - | - | - | - | 60.17 | - |
Cash & Short-Term Investments | 109.53 | 125.55 | 172.68 | 200.02 | 217.48 | 236.98 |
Cash Growth | -28.38% | -27.29% | -13.67% | -8.03% | -8.23% | -0.16% |
Other Receivables | 0.29 | 0.36 | 0.86 | 0.94 | 1.76 | 8.95 |
Receivables | 0.29 | 0.36 | 0.86 | 0.94 | 1.76 | 8.95 |
Prepaid Expenses | 1.34 | 1.04 | 1.03 | 0.76 | 0.6 | 0.93 |
Total Current Assets | 111.16 | 126.95 | 174.57 | 201.72 | 219.84 | 246.87 |
Property, Plant & Equipment | 22.49 | 23.13 | 24.53 | 24.9 | 26.26 | 28.31 |
Total Assets | 133.65 | 150.08 | 199.09 | 226.62 | 246.1 | 275.18 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.11 | 1.54 | 2.22 | 2.52 | 2.41 | 2.07 |
Accrued Expenses | 2.25 | 6.32 | 2.63 | 3.5 | 1.6 | 1.37 |
Short-Term Debt | - | - | 10.25 | - | - | - |
Current Income Taxes Payable | - | 0.08 | - | 0.08 | 0.06 | 0.01 |
Total Current Liabilities | 3.35 | 7.93 | 15.11 | 6.1 | 4.07 | 3.45 |
Long-Term Deferred Tax Liabilities | 0.01 | 0.01 | - | - | 0.06 | 0.87 |
Other Long-Term Liabilities | 1.83 | 1.8 | 1.72 | 1.67 | 1.58 | 1.47 |
Total Liabilities | 5.19 | 9.73 | 16.83 | 7.77 | 5.7 | 5.79 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 277.07 | 276.73 | 273.11 | 271.15 | 267.33 | 262.26 |
Retained Earnings | -148.61 | -136.38 | -90.84 | -52.31 | -27.75 | 5.15 |
Comprehensive Income & Other | - | - | - | - | 0.83 | 1.97 |
Shareholders' Equity | 128.46 | 140.35 | 182.27 | 218.85 | 240.4 | 269.39 |
Total Liabilities & Equity | 133.65 | 150.08 | 199.09 | 226.62 | 246.1 | 275.18 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | 10.25 | - | - | - |
Net Cash (Debt) | 109.53 | 125.55 | 162.43 | 200.02 | 217.48 | 236.98 |
Net Cash Growth | -28.38% | -22.70% | -18.80% | -8.03% | -8.23% | -0.16% |
Net Cash Per Share | 3.59 | 4.12 | 5.33 | 6.57 | 7.14 | 7.89 |
Filing Date Shares Outstanding | 30.49 | 30.49 | 30.49 | 30.45 | 30.44 | 30.44 |
Total Common Shares Outstanding | 30.49 | 30.49 | 30.49 | 30.44 | 30.44 | 30.44 |
Working Capital | 107.81 | 119.02 | 159.46 | 195.62 | 215.78 | 243.42 |
Book Value Per Share | 4.21 | 4.60 | 5.98 | 7.19 | 7.90 | 8.85 |
Tangible Book Value | 128.46 | 140.35 | 182.27 | 218.85 | 240.4 | 269.39 |
Tangible Book Value Per Share | 4.21 | 4.60 | 5.98 | 7.19 | 7.90 | 8.85 |
Land | - | 1.42 | 1.42 | 1.42 | 1.42 | 1.42 |
Buildings | - | 24.17 | 24.17 | 24.17 | 24.17 | 22.77 |
Machinery | - | 17.23 | 17.03 | 16.89 | 16.57 | 17.6 |
Construction In Progress | - | 1.79 | 1.71 | 0.47 | 0.4 | 2.06 |